Suppr超能文献

对因妊娠剧吐入院的女性所开具出院治疗方案的评估。

Assessment of discharge treatment prescribed to women admitted to hospital for hyperemesis gravidarum.

作者信息

Fiaschi Linda, Housley Gemma, Nelson-Piercy Catherine, Gibson Jack, Raji Ayokunnu, Deb Shilpa, Tata Laila J

机构信息

Division of Epidemiology & Public Health, City Hospital, University of Nottingham, Nottingham, UK.

Nottingham University Hospitals and East Midlands Academic Health Science Network, Nottingham, UK.

出版信息

Int J Clin Pract. 2019 Jan;73(1):e13261. doi: 10.1111/ijcp.13261. Epub 2018 Sep 21.

Abstract

AIMS

Prescribing drug treatment for the management of hyperemesis gravidarum (HG), the most severe form of nausea and vomiting in pregnancy, remains controversial. Since most manufacturers do not recommend prescribing antiemetics during pregnancy, little is known regarding which treatments are most prevalent among pregnant patients. Here, we report for the first time, evidence of actual treatments prescribed in English hospitals.

METHODS

A retrospective pregnancy cohort was constructed using anonymised electronic records in the Nottingham University Hospitals Trust system for all women who delivered between January 2010 and February 2015. For women admitted to hospital for HG, medications prescribed on discharge were described and variation by maternal characteristics was assessed. Compliance with local and national HG treatment guidelines was evaluated.

RESULTS

Of 33 567 pregnancies (among 30 439 women), the prevalence of HG was 1.7%. Among 530 HG admissions with records of discharge drugs, cyclizine was the most frequently prescribed (almost 73% of admissions). Prochlorperazine and metoclopramide were prescribed mainly in combination with other drugs; however, ondansetron was more common than metoclopramide at discharge from first and subsequent admissions. Steroids were only prescribed following readmissions. Thiamine was most frequently prescribed following readmission while high dose of folic acid was prescribed equally after first or subsequent admissions. Prescribing showed little variation by maternal age, ethnicity, weight, socioeconomic deprivation, or comorbidities.

CONCLUSION

Evidence that management of HG in terms of discharge medications mainly followed local and national recommendations provides reassurance within the health professional community. Wider documentation of drugs prescribed to women with HG is required to enable full assessment of whether optimal drug management is being achieved.

摘要

目的

对于妊娠剧吐(HG),即孕期最严重的恶心和呕吐形式,开具药物治疗方案仍存在争议。由于大多数制药商不建议在孕期开具止吐药,因此对于哪些治疗方法在孕妇中最为普遍知之甚少。在此,我们首次报告了英国医院实际开具的治疗方法的证据。

方法

利用诺丁汉大学医院信托系统中的匿名电子记录,为2010年1月至2015年2月期间分娩的所有女性构建了一个回顾性妊娠队列。对于因HG入院的女性,描述出院时开具的药物,并评估产妇特征的差异。评估了对当地和国家HG治疗指南的依从性。

结果

在33567例妊娠(30439名女性)中,HG的患病率为1.7%。在530例有出院药物记录的HG入院病例中,赛克利嗪是最常开具的药物(几乎占入院病例的73%)。氯丙嗪和甲氧氯普胺主要与其他药物联合使用;然而,在首次及后续入院出院时,昂丹司琼比甲氧氯普胺更常用。类固醇仅在再次入院后开具。硫胺素在再次入院后最常开具,而高剂量叶酸在首次或后续入院后开具的频率相同。开具情况在产妇年龄、种族、体重、社会经济剥夺或合并症方面差异不大。

结论

关于出院药物治疗方面HG管理主要遵循当地和国家建议的证据,在卫生专业人员群体中提供了 reassurance(此处reassurance 可理解为“安心感、信心”等类似意思,结合语境具体确定)。需要更广泛地记录为HG女性开具的药物,以便全面评估是否实现了最佳药物管理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验